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Thyroid hormones (TH) play several essen-
tial roles for brain maturation in humans. 
Adequate levels are necessary at specific times 
in certain regions of the brain for the nor-
mal development of the nervous system dur-
ing fetal and neonatal periods (Porterfield 
and Hendrich 1993). Maternal TH are 
the only source of TH for the developing 
brain of the fetus during the first trimester 
of pregnancy, at the end of which the fetal 
  hypothalamic–pituitary system initiates its 
own TH synthesis and secretion (Calvo et al. 
2002). Studies have demonstrated that mater-
nal TH can regulate gene expression in the 
fetal cortex, but their action on the devel-
oping brain remains unclear (Dowling and 
Zoeller 2000). Any alteration of maternal 
and/or fetal TH availability during critical 
periods of TH-dependent action may have 
a detrimental impact on the developing fetal 
brain, as previously demonstrated in animal 
and human studies (Morreale de Escobar 
et al. 2000; Pop et al. 2003).
Prenatal exposure to polychlorinated 
biphenyls (PCBs), a group of persistent and 
lipophilic organochlorine compounds (OCs), 
has been associated with neurodevelopmental 
deficits in childhood in most cohort studies 
focusing on developmental neurotoxicity of 
PCBs (Jacobson and Jacobson 1996; Stewart 
et al. 2008). Animals studies have reported 
detrimental effects of in utero exposure to 
PCBs on cognitive (Schantz and Widholm 
2001) and motor functions (Schantz et al. 
1997) as well as on the auditory system 
(Goldey et al. 1995). At the biochemical level, 
several PCB congeners disrupt the thyroid 
function, principally by lowering plasma thy-
roxine (T4) (Brouwer et al. 1995) and greatly 
depressing T4 concentrations in brain tissue 
in rats exposed prenatally (Morse et al. 1996). 
Hexachlorobenzene (HCB) has been 
used as a fungicide and is also a by-product 
of the manufacturing of chlorinated solvents 
and metallurgical processes. HCB is found 
worldwide because of its long-range atmo-
spheric transport, is very persistent, and tends 
to accumulate in adipose tissues. Exposure 
to HCB in rats can produce several effects 
including reduced T4 plasma levels and hypo-
thyroidism (van Raaij et al. 1993). HCB has 
been shown to interfere with T4 uptake into 
the cerebrospinal fluid in rats (van Raaij et al. 
1994). 
Transport of T4 across the blood–brain 
barrier by transthyretin (TTR) is one mecha-
nism by which TH reaches the developing 
fetal brain (Schreiber et al. 1995) and also 
facilitates maternal transfer across the placenta 
(Brouwer et al. 1998). Some chlorinated phe-
nolic compounds (CPC) such as the hydroxy-
lated metabolites of PCBs (HO-PCBs) and 
pentachlorophenol (PCP) possess a greater 
in vitro binding affinity for TTR than the 
natural ligand T4 (van den Berg 1990). 
Furthermore, HO-PCBs and PCP can 
strongly inhibit TH sulfation (Schuur et al. 
1998), which along with desulfation appear 
to be very important pathways regulating 
circulating TH concentrations in the fetus 
(Darras et al. 1999). 
Results from epidemiologic studies among 
pregnant women are scarce, but suggest 
potential effects of OCs on thyroid economy 
(Chevrier et al. 2008; Koopman-Esseboom 
et al. 1994; Takser et al. 2005). In contrast, 
assessments of the relation between environ-
mental contaminants and the thyroid sta-
tus of newborns have resulted in equivocal 
findings, possibly because of differences in 
the biological matrices for exposure deter-
mination (blood, plasma, placenta, or breast 
milk), the contaminants measured, and the 
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Ba c k g r o u n d: An increasing number of studies have shown that several ubiquitous environmental 
contaminants possess thyroid hormone–disrupting capacities. Prenatal exposure to some of them, 
such as polychlorinated biphenyls (PCBs), has also been associated with adverse neurodevelopmental 
effects in infants. 
oBjectives: In this study we examined the relationship between exposure to potential thyroid 
hormone–disrupting toxicants and thyroid hormone status in pregnant Inuit women from Nunavik 
and their infants within the first year of life.
Me t h o d s : We measured thyroid hormone parameters [thyroid stimulating hormone (TSH), free 
thyroxine (fT4), total triiodothyronine (T3), thyroxine-binding globulin (TBG)] and concentrations 
of several contaminants [PCB-153, hydroxylated metabolites of PCBs (HO-PCBs), pentachloro-
phenol (PCP) and hexachlorobenzene (HCB)] in maternal plasma at delivery (n = 120), in umbili-
cal cord plasma (n = 95), and in infant plasma at 7 months postpartum (n = 130).
re s u l t s: In pregnant women, we found a positive association between HO-PCBs and T3 concentra-
tions (β = 0.57, p = 0.02). In umbilical cord blood, PCB-153 concentrations were negatively associ-
ated with TBG levels (β = –0.26, p = 0.01). In a subsample analysis, a negative relationship was also 
found between maternal PCP levels and cord fT4 concentrations in neonates (β = –0.59, p = 0.02). 
No association was observed between contaminants and thyroid hormones at 7 months of age.
co n c l u s i o n: Overall, there is little evidence that the environmental contaminants analyzed in this 
study affect thyroid hormone status in Inuit mothers and their infants. The possibility that PCP 
may decrease thyroxine levels in neonates requires further investigation. 
key w o r d s : cohort, cord blood, Inuit, metabolites, organochlorines, pentachlorophenol, poly-
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congener grouping as well as the timing of 
postnatal TH dosage (Maervoet et al. 2007). 
With regard to CPCs, only two studies have 
investigated their effects in newborns and 
found opposite results (Otake et al. 2007; 
Sandau et al. 2002). 
Because the potential effects of thyroid-
disrupting contaminants on maternal and 
neonatal thyroid status are not yet clear, we 
undertook a study to determine the relation-
ship of background exposure to OCs and 
CPCs with TH status in pregnant women 
and their infants within the first year of 
the infant's life. This study addresses this 
research question among the Inuit popula-
tion of Nunavik because these communities 
are among the most heavily exposed to these 
contaminants on earth, mainly through sea 
mammal consumption. 
Materials and Methods
Population. Nunavik is the northern region of 
Québec where approximately 9,500 Inuit live 
in 14 communities on the coast of the Hudson 
and Ungava Bays. All pregnant Inuit women 
from the three largest communities of the 
Hudson Bay coast of Nunavik were invited to 
participate in a study that aimed to document 
the effects of prenatal exposure to environmen-
tal contaminants on infant development. 
From November 1995 to March 2001, 
a research assistant contacted each potential 
participant after her first prenatal visit with a 
midwife or a nurse. All pregnant women gave 
informed consent for themselves and for their 
infants before participating in the study. The 
study protocol was approved by the Nunavik 
Nutrition and Health Committee and by eth-
ics committees at Laval University (Québec 
City, Québec, Canada) and Wayne State 
University (Detroit, Michigan). One prena-
tal and two postnatal (at 1 and 6 months) 
interviews were conducted to obtain socio-
demographic and personal information from 
the mothers. The participation rate for this 
study was 69%. Among the 248 participating 
mother–infant dyads, 17.8% were excluded 
due to the adoption of the newborn, fetal or 
postnatal mortality, and loss to follow-up. 
Biological data on TH and OC concentra-
tions were available for 204 pregnant women. 
Because TH levels slowly return to non-
pregnancy levels after delivery and to ensure 
that measured levels of TH were not related 
to postpartum thyroid dysfunction, which 
occurs between 2 and 12 months postpar-
tum (Stagnaro-Green 2004), mothers from 
whom the blood sample was drawn 31 days 
after delivery were excluded from the statisti-
cal analysis (n = 71). Pregnant women who 
declared using medication for thyroid diseases 
were also excluded (n = 4). Biological data 
on TH and OC concentrations were avail-
able for 108 infants at birth and 175 infants 
at 7 months of age. Neonates born prema-
turely and/or with low birth weight were also 
excluded because transient neonatal hypothy-
roxinemia may be induced by prematurity 
(< 37 weeks gestation, n = 6) and low birth 
weight (< 2,500 g, n = 1) (Fisher 1998). 
Blood sampling and laboratory procedures. 
A 12.5-mL blood sample was collected from 
participating women at delivery or within the 
subsequent weeks (median = 2 days). A 30-mL 
blood sample was collected from the umbilical 
cord after it was severed, and a 5-mL blood 
sample was obtained at 7 months postpartum 
(median = 6.9 months). OC, CPC, and TH 
levels were measured in maternal, cord, and 
infant plasma. Selenium and plasma lipid con-
centrations were also measured in samples for 
confounding assessment. 
Blood samples were collected in vials 
containing EDTA as the anticoagulant and 
centrifuged (10 min, 5,000 rpm), and the 
plasma transferred into glass vials prewashed 
with hexane. Plasma samples were frozen at 
–80°C until time of analysis. We measured 
concentrations of the 14 most frequently 
detected PCB congeners in human popula-
tions [IUPAC (International Union of Pure 
and Applied Chemistry) nos. 28, 52, 99, 101, 
105, 118, 128, 138, 153, 156, 170, 180, 
183, 187] and HCB in the purified extracts 
using an HP-5890 series II gas chromato-
graph (Hewlett-Packard, Palo Alto, CA, 
USA) equipped with dual-capillary columns 
(HP Ultra and Ultra II; Hewlett-Packard) 
and dual Ni-63 electron capture detectors 
(Hewlett-Packard). Detailed laboratory proce-
dures and quality control procedures for OCs 
were described previously by Rhainds et al. 
(1999) and Muckle et al. (2001), respectively. 
Limits of detection for OCs were 0.02 µg/L.
We determined concentrations of CPCs 
by extracting the plasma samples on an Oasis 
HLB (540 mg; Waters Corp., Milford, MA, 
USA) solid phase extraction column accord-
ing to a modified method by Sandau et al. 
(2003). Extraction and cleanup were com-
pleted on a Zymark Rapidtrace Automated 
SPE workstation (Zymark Corp., Hopkinton, 
MA,  USA).  CPCs  were  eluted  with 
dichloromethane:methanol (9:1) in a third 
fraction on a prepacked Florisil column (1 g; 
Alltech, Lexington, KY, USA). After evapora-
tion, the compounds were derivatized using 
diazomethane in hexane according to the 
method of Sandau (2000). The derivatized 
fraction was then cleaned up on an activated 
silica/acidic silica column before evaporation, 
addition of recovery standard, and quantifica-
tion by gas chromatography/high resolution 
mass spectrometry. HO-PCB results are pre-
sented as a sum of the 11 major HO-PCBs 
(4-HO-CB-107, 3-HO-CB-153, 4-HO-CB-
146, 3´-HO-CB-138, 4-HO-CB-163, 4-HO-
CB-187, 4-HO-CB-202, 4´-HO-CB-172, 
4-HO-CB-193, 4´-HO-CB-199, and 4-HO-
CB-208). The limit of detection for those 
compounds varied between 2 and 6 ng/L.
We determined total cholesterol, free 
cholesterol, and triglycerides in plasma by 
standard enzymatic procedures, whereas 
we quantified phospholipids according to 
Takayama et al. (1977) using a commer-
cial kit (Wako Pure Chemical Industries, 
Richmond, VA, USA). Concentrations of 
total plasma lipids were estimated accord-
ing to the formula developed by Akins et al. 
(1989). Blood Se concentrations were deter-
mined using inductively coupled plasma mass 
spectrometry (PE Elan 6000; PerkinElmer 
Sciex, Concord, ON, Canada). The limit of 
detection for blood Se was 0.1 µmol/L. 
We analyzed serum throid-stimulating 
hormone (TSH), free T4 (fT4), total tri-
iodothyronine (T3), and thyroid-binding 
globulin (TBG), the major transport protein 
of TH, using radioimmunoassay methods. 
TSH, fT4, and T3 were measured on the Bayer 
Immuno 1 System (Bayer Corp., Tarrytown, 
NY, USA). TBG was determined on the 
Clinical Assays GammaDab system commer-
cialized by DiaSorin (Stillwater, MN, USA). 
Statistical analysis. Contaminant concen-
trations and thyroid parameters were all log-
transformed to satisfy criteria of normality. 
We used Pearson correlations to evaluate rela-
tions between contaminants, and simple and 
multiple linear regression models to evaluate 
the relationship between environmental con-
taminants, TH, and TBG in plasma. A value 
equal to half the limit of detection of the ana-
lytical method was attributed to nondetected 
contaminants in biological samples. Only 
PCB congeners with a detection frequency 
of at least 70% were considered. We evalu-
ated exposure to PCB by several approaches. 
First, all PCB congeners were evaluated indi-
vidually. Second, congeners were grouped 
according to their dioxin-like activity or their 
capacity to induce the microsomal enzymes 
UDP-GT (uridine diphosphate-glucuronosyl 
transferase), CYP1A (cytochrome P4501A), 
and CYP2B as proposed by Wolff et al. 
(1997). For the later grouping, the enzyme-
inducing congeners included were PCBs 99, 
118, 153, 180, and 187. Third, because all 
PCB congeners were highly correlated in the 
study population, PCB-153 was selected as a 
marker of exposure to all PCBs (Muckle et al. 
2001). Indeed, in maternal plasma, intercor-
relations among PCB congeners varied from 
0.62 to 0.96. Similarly, in cord and infant 
plasma, intercorrelations among PCB con-
geners varied from 0.73 to 0.98 and 0.81 
to 0.99, respectively. Correlations between 
PCB-153 and the sum of PCB inducers 
in maternal, cord, and infant plasma were 
all 0.99. Because results obtained using all 
PCB congeners or groupings did not change Dallaire et al.
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significantly from those obtained with 
PCB-153 (data not shown), only results for 
PCB-153 are presented.
We performed simple regressions between 
potential confounding variables and thy-
roid parameters to determine which cova-
riate should be included in multiple linear 
regression analyses. Covariates associated at 
a p-value ≤ 0.10 were included in multiple 
regression models to assess their confounding 
influence. Covariates modifying the regres-
sion coefficient of the contaminants by > 10% 
with any of the TH were included in adjusted 
models for all TH parameters. The following 
covariates were evaluated in pregnant women: 
age at delivery, prepregnancy body weight, 
socioeconomic status [Hollingshead Index 
of Social Status (Hollingshead AB, unpub-
lished data)], alcohol and cigarette consump-
tion, fish consumption during pregnancy, 
and plasma Se concentration. Because age 
at delivery and parity were highly intercor-
related, only the former was retained in the 
multiple models, where appropriate, because 
it was a better predictor of TH concentra-
tions in pregnant women. Nine women were 
not included in statistical analysis because 
of absence of information regarding alcohol 
consumption. Most variables evaluated as 
potential confounders in newborns were also 
tested in the models at 7 months of age. The 
primary caregiver’s score for socioeconomic 
status, maternal alcohol and cigarette con-
sumption, maternal fish consumption dur-
ing pregnancy, sex, breast-feeding status, as 
well as Se level in cord blood were tested for 
confounding at both ages. Gestational age 
and birth weight were also highly intercorre-
lated in newborns. Therefore, only the former 
was included in multiple regression models, 
where appropriate, because it was a better pre-
dictor of TH concentrations. Six newborns 
were excluded due to unmeasured cord sele-
nium concentrations, and 15 infants were 
excluded for lack of information regarding 
breast-feeding status. Because breast-feeding is 
an important source of postnatal exposure, an 
interaction term between OC concentrations 
and breast-feeding status at 7 months of age 
was also tested in multiple regression models. 
Statistical models assessing the relationship 
between the lipophilic contaminants PCB-153 
or HCB and thyroid parameters were further 
adjusted for total plasma lipid concentrations 
because Schisterman et al. (2005) have shown 
that this approach is less prone to estimate 
bias compared with lipid standardization. 
Adjustment for lipid content was not done 
for CPCs because they are bound to plasma 
proteins (Sandau et al. 2000). 
A bilateral p-value < 0.05 was considered 
statistically significant. Database manage-
ment and variable transformation were per-
formed with SPSS (version 2.0; SPSS Inc., 
Chicago, IL, USA) whereas statistical analyses 
were conducted with SAS (version 9.1; SAS 
Institute Inc., Cary, NC, USA).
Results 
Table 1 lists the characteristics of included 
and excluded pregnant Inuit women and 
their infants at birth and at 7 months of age. 
Sociodemographic characteristics and exposure 
to OCs (data not shown) were similar between 
Table 1. Characteristics of included and excluded mothers and their infants.
  Included  Excluded 
Characteristic  No.  Mean ± SD  No.  Mean ± SD  p-Value
Maternal
  Age (years)  120  24.9 ± 5.9  119  25.2 ± 5.7  0.73
  Marital status (% single)  120  31.0  128  27.0  0.38
  Education (years)  120  8.9 ± 1.7  128  9.0 ± 1.8  0.68
  Prepregnancy weight (kg/m2)  120  61.1 ± 11.9  123  61.9 ± 12.0  0.62
  Parity  120  2.0 ± 1.9  128  2.1 ± 1.8  0.91
  No. of cigarettes/day (%)         
  0  12  10  12  9  0.87
  1–10  59  49  62  48  0.91
  11–24  38  32  46  36  0.48
  ≥ 25   11  9  11  6  0.39
  Average absolute alcohol/drinking day (oz)a  120  0.76 ± 0.8  95  0.70 ± 0.66  0.53
  Plasma selenium (µmol/L)  86  1.34 ± 0.35  83  1.40 ± 0.38  0.55
  No. of meals of fish/week   120  3.6 ± 4.3  95  3.1 ± 3.5  0.30
Neonate
  Gestational age (weeks)  95  39.1 ± 1.3  135  38.2 ± 2.0  < 0.01
  Sex (% male)  95  62.1    53.3  0.18
  Weight (g)  95  3,616 ± 449  143  3,301 ± 624  < 0.01
  Height (cm)  94  50.9 ± 1.7  116  49.7 ± 2.5  < 0.01
  Breast-fed at birth (%)  77  54  171  25  < 0.01
  Umbilical cord Se (µmol/L)  95  3.68 ± 1.56  12  3.42 ± 0.79  0.56
Infant 
  Age (days)  130  235 ± 70  61  228 ± 51  0.47
  Sex (% male)  130  60.8  100  52.0  0.18
  Weight (kg)  123  9.7 ± 1.3  47  9.6 ± 1.3  0.77
  Height (cm)  125  67.4 ± 3.5  51  67.7 ± 3.1  0.60
  Breast-fed at 7 months (%)  130  51  118  16  < 0.01
a0.5 oz absolute alcohol corresponds to 12 oz beer, 6 oz wine, or 1.5 oz liquor.
Table 2. Concentrations of organochlorines and chlorinated phenolic compounds in plasma from pregnant Inuit women and their infants at birth and at 7 months 
of age.
  Lipid standardized concentrations (µg/kg)  Wet weight concentrations (µg/L)a
    Percent   Geometric      Geometric  Pearson correlations
Analytes  No.  detected  mean  95% CI  Range  mean  95% CI  Range  HCB  ΣHO-PCBs   PCP 
Maternal       
  PCB-153   120  100  107.7  93.2–124.5  15.6–709.0  0.89  0.77–1.04  0.01–6.12  0.69#  0.84#  0.34
  HCB   120  100  41.1  36.5–46.1  6.7–352.6  0.34  0.30–0.39  0.05–2.78    0.65#  0.32
  ΣHO-PCBsa   25  —    —  —  316  245–409  109–1,517      0.36
  PCPa   25  100    —  —  931  772–1,123  241–2,898     
Cord       
  PCB-153   95  100  83.1  70.4–98.0  12.0–550.9  0.20  0.17–0.24  0.03–2.42  0.70#  0.82#  0.17
  HCB   95  100  42.9  38.0–48.4  10.6–184.5  0.11  0.09–0.12  0.02–0.83    0.60#  0.12
  ΣHO-PCBsa   41  —    —  —  246  195–309  65–1,358      0.23
  PCPa   41  100    —  —  1,078  923–1,267  300–2,913     
Infant 
  PCB-153   130  98.0  90.5  72.9–112.3  < LOD–1387.3  0.45  0.36–0.57  < LOD–8.54  0.92#  —  —
  HCB   130  95.9  41.5  34.1–50.5  < LOD–446.7  0.21  0.17–0.26  < LOD–2.75      —
Abbreviations: CI, confidence interval; LOD, Limit of detection.
aΣHO-PCBs and PCP concentrations are expressed in pg/g wet weight. #p < 0.001.Environmental contaminants and thyroid hormone status
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the pregnant women who were included and 
and those excluded from the study. In accor-
dance with the exclusion criteria, newborns 
included in the study had a longer gestational 
age and were heavier. Percentages of breast-
feeding at birth and at 7 months of age were 
significantly greater in infants included than in 
those excluded. There was no significant dif-
ference in exposure to OCs between included 
and excluded infants at birth and at 7 months 
of age (data not shown).
Table 2 presents descriptive statistics for 
OCs and CPCs in maternal, cord, and infant 
plasma. PCB-153 is the most prevalent conge-
ner in this population The mean concentration 
of PCB-153 was higher in pregnant women, 
followed by infant and cord plasma levels. The 
correlation on a lipid basis between maternal 
and cord plasma PCB-153 was very high (r = 
0.94), but only moderate between maternal and 
infant concentrations (r = 0.41) and cord and 
infant concentrations (r = 0.46). Mean lipid-
adjusted HCB concentrations were similar for 
newborn, infant, and maternal plasma samples. 
As for PCB-153, the correlation between mater-
nal and cord plasma HCB was high (r = 0.86), 
but in the moderate range between mater-
nal and infant concentrations (r = 0.33) and 
cord and infant concentrations (r = 0.36). The 
mean wet weight concentration of HO-PCBs 
was higher in pregnant women than in cord 
plasma, and levels were highly intercorrelated 
(r = 0.96). Most of the HO-PCBs detected in 
mothers and newborns were moderately cor-
related with PCB-153 (r = 0.21–0.78, median: 
newborn r = 0.63; maternal r = 0.53) on a wet 
weight basis. PCP was detected in all mater-
nal and umbilical cord plasma samples. Levels 
were higher in umbilical cord than in maternal 
plasma and were also very highly correlated (r 
= 0.85). Intercorrelations of contaminants in 
maternal, umbilical cord, and infant plasma are 
also presented in Table 2. In maternal and cord 
samples, PCB-153 concentrations were highly 
correlated with HO-PCBs and moderately with 
HCB. Also, PCP was weakly correlated with 
the other contaminants. Concentrations of 
PCB-153 and HCB were highly correlated in 
infant plasma. 
A large proportion of the mothers had 
TSH values outside the TSH euthyroid refer-
ence range (0.4–2.5 mIU/L) (Demers and 
Spencer 2002). Sixteen percent (n = 20) had 
TSH concentrations below the lower limit 
whereas 10% (n =13) had values higher than 
the reference range. There were no significant 
differences in OC concentrations between 
mothers outside and within the TSH euthy-
roid refence range. Most infants at birth and 
at 7 months of age had TSH and fT4 levels 
within the normal range (Demers and Spencer 
2002; Hume et al. 2004).
The associations between OCs and CPCs 
and the thyroid parameters documented in 
pregnant women at delivery are presented in 
Table 3. Simple regression models showed 
a significant positive association between 
HO-PCBs and T3. Simple and multiple 
regressions between contaminants and TSH 
as well as fT4 were not significant. Adjustment 
for confounding factors strengthens the posi-
tive association between HO-PCBs and T3. 
Table 4 shows simple and multiple linear 
associations between thyroid parameters mea-
sured in umbilical cord blood and OCs or 
CPCs levels in cord and maternal plasma. In 
newborns at birth, no significant association 
was observed between cord blood contami-
nants and TH concentrations in univariate 
models. However, negative associations were 
found for umbilical cord and maternal 
PCB-153 with TBG concentrations after 
control for confounders. A negative associa-
tion between cord fT4 and maternal PCP, but 
not cord PCP, was found before and after 
controlling for confounders. In the subsample 
analysis of cord CPC, characteristics of new-
borns included were similar, except that those 
included had a higher birth weight (included: 
mean = 3,758 g, excluded: mean = 3,508 g, 
p = 0.006). Also, in the subsample analysis of 
maternal CPC, characteristics of mothers and 
newborns were similar, except that mater-
nal and cord Se concentrations were lower 
(mothers included: mean = 1.09 µmol/L, 
excluded: mean = 1.44 µmol/L, p = 0.01; 
newborns included: mean = 3.11 µmol/L, 
excluded: mean = 3.84 µmol/L, p = 0.04). 
Concentrations of T3 in cord blood were 
not associated with any of the contaminants 
under study. A significant negative association 
between PCB-153 and TSH was obtained in 
simple linear regression for infants 7 months 
of age (Table 5). However, the association 
was no longer significant after adjustment 
for breast-feeding status. Interaction terms 
Table 3. Linear regression models of thyroid hormones and TBG plasma levels with organochlorines and 
chlorinated phenolic compounds in plasma from pregnant Inuit women. 
Analyte   Thyroid parameter  No.  Univariate β  Standardized β
PCB-153 (µg/L)a  TSH (mIU/L)  120  –0.05  0.05
  fT4 (pmol/L)  120  –0.01  –0.05
 T 3 (nmol/L)  120  0.01  0.08
  TBG (nmol/L)  120  0.03  0.13
HCB (µg/L)a  TSH (mIU/L)  120  0.03  0.13
  fT4 (pmol/L)  120  0.02  0.07
  T3 (nmol/L)  120  0.02  0.07
  TBG (nmol/L)  120  0.05  0.15
ΣHO-PCBs (pg/g wet weight)  TSH (mIU/L)  25  –0.14  0.08
  fT4 (pmol/L)  25  –0.05  –0.40
 T 3 (nmol/L)  25  0.16**  0.57*
  TBG (nmol/L)  25  0.14  0.30
PCP (pg/g wet weight)  TSH (mIU/L)  25  0.35  0.27
  fT4 (pmol/L)  25  –0.11  –0.22
  T3 (nmol/L)  25  0.10  0.16
  TBG (nmol/L)  25  0.08  0.06
Standardized β adjusted for age at delivery, alcohol (average absolute alcohol/drinking day), and cigarette (cigarettes/
day) consumption during pregnancy.
aAlso adjusted for serum lipid concentrations. *p < 0.05. **p = 0.01. 
Table 4. Linear regression models of thyroid hormone and TBG levels in umbilical cord with organo  chlorine 
and chlorinated phenolic compounds in maternal and umbilical cord plasma.
  Thyroid  Cord contaminants  Maternal contaminants
Analyte   parameter   No.  Univariate β  Standardized β  No.  Univariate β  Standardized β
PCB-153 (µg/L)a   TSH (mIU/L)  95  0.01  –0.05  80  0.06  0.02
  fT4 (pmol/L)  95  –0.02  –0.14  80  –0.02  –0.14
 T 3 (nmol/L)  95  –0.01  –0.04  80  0.03  0.04
  TBG (nmol/L)  95  –0.05  –0.26**  80  –0.05  –0.25**
HCB (µg/L)a   TSH (mIU/L)  95  –0.02  –0.09  80  –0.02  –0.10
  fT4 (pmol/L)  95  0.00  –0.04  80  0.00  –0.02
 T 3 (nmol/L)  95  –0.06  –0.18  80  0.00  –0.09
  TBG (nmol/L)  95  –0.03  –0.15  80  –0.01  –0.15
ΣHO-PCBs   TSH (mIU/L)   41  –0.04  –0.12  19  0.06  0.05
(pg/g wet weight)   fT4 (pmol/L)  41  0.00  –0.08  19  0.02  0.05
 T 3 (nmol/L)  41  0.05  0.10  19  0.15  0.17
  TBG (nmol/L)  41  –0.06  –0.25  19  0.00  –0.02
PCP   TSH (mIU/L)   41  –0.01  0.02  19  –0.01  –0.05
(pg/g wet weight)  fT4 (pmol/L)  41  –0.05  –0.20  19  –0.13**  –0.59*
 T 3 (nmol/L)  41  –0.18  –0.31  19  –0.07  –0.11
  TBG (nmol/L)  41  –0.09  –0.28  19  –0.11  –0.34
Standardized β adjusted for gestational age, cord selenium, and maternal cigarette (cigarettes/day) consumption during 
pregnancy.
aAlso adjusted for serum lipid concentrations. *p < 0.05. **p = 0.01.Dallaire et al.
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between OCs and breast-feeding status were 
not significant. The associations were not sig-
nificant after stratification for breast-feeding 
status (data not shown).
Discussion
In the present study, we investigated the 
potential negative effects of OCs and 
CPCs on the circulating concentrations of 
TH among Inuit women and their infants. 
Overall, the results show that plasma concen-
tration of OCs and CPCs were not significant 
predictors of TSH and TH concentrations in 
this population of pregnant women and their 
offspring. However, maternal levels of PCP 
were negatively associated with fT4 concen-
trations in umbilical cord blood of neonates, 
suggesting that this compound may reduce 
the transfer of maternal T4 across the placenta 
to the developing fetus.
As reported in most studies [reviewed by 
Maervoet et al. (2007)], an association between 
PCB-153 and TH concentrations was not 
found in Inuit neonates at birth. Similarly, 
no association was seen in these infants 
at the 7-months follow-up. Also, these data 
did not corroborate the relationship between 
PCB congeners and TSH or TH levels seen 
in the CHAMACOS (Center for the Health 
Assessment of Mothers and Children of 
Salinas) study (Chevrier et al. 2007), in any of 
the exposure matrices (maternal, cord, or infant 
plasma). These associations were observed even 
though the maternal PCB-153 concentrations 
were almost 20 times lower than those in the 
present study. Difference in the profile of other 
PCB congeners in that population may pro-
vide one explanation for the discrepancy in 
results between the CHAMACOS study and 
the present study. Another possible impor-
tant difference between both populations is the 
iodine intake. Indeed, iodine, which is essential 
for thyroid function, is found in high concen-
tration in some seafood products. Therefore, 
exposure to iodine and OCs co-occurs in 
individuals such as the Nunavik Inuit, who 
consume a large amount of marine products. 
Therefore, not taking into account urinary 
iodine concentrations in epidemiologic stud-
ies aiming to investigate this research question 
may partly explain the inconsistent results.
The absence of an association between 
HCB and umbilical cord fT4 concentrations 
in this study are not consistent with a previ-
ous finding of significant positive associations 
in another sample of Inuit neonates and in 
newborns from the Lower North Shore of 
the St. Lawrence River (Dallaire et al. 2008). 
The lower statistical power of the present 
study as well as a difference in adjustment of 
confounders may account for the differential 
results. However, the absence of relationship 
between HCB and fT4 found in the present 
study are in agreement with two other epide-
miologic studies among neonates (Ribas-Fito 
et al. 2003; Takser et al. 2005).
The absence of an association between 
PCB-153 and thyroid parameters in pregnant 
Inuit women was similar to that reported in 
the second Faroe Islands cohort (Steuerwald 
et al. 2000). However, two other epide-
miologic studies among pregnant women 
found a significant negative association of 
PCBs with T3 and/or tT4 status (Koopman-
Esseboom et al. 1994; Takser et al. 2005) 
whereas, among Mexican-American pregnant 
women, three PCB congeners (44, 52, and 
183) were negatively related to fT4 concen-
trations (Chevrier et al. 2008). It is possible 
that the effects observed in these three studies 
were mostly attributable to the exposure to 
polychlorinated dibenzo-p-dioxins and poly-
chlorinated dibenzofurans, which are usu-
ally higher in urban settings than in isolated 
populations mostly exposed to environmental 
contaminants through fish and marine mam-
mal consumption. As previously mentioned, 
high dietary iodine intake in fish-eating popu-
lations may also explain the lack of associa-
tion between PCB-153 and thyroid hormone 
status in mothers (Dallaire et al. 2008).
HCB body burden was not associated 
with thyroid hormone profile in Inuit preg-
nant women at delivery. Two other studies 
investigated whether exposure to low back-
ground concentrations of HCB was related to 
TH levels during pregnancy. An inverse rela-
tionship between plasma HCB concentrations 
and T3 levels was reported among Canadians 
(Takser et al. 2005), and negative associations 
between HCB concentrations and fT4 and 
tT4 levels were found in the CHAMACOS 
study (Chevrier et al. 2008). However, the 
authors were not able to determine whether 
effects on TH concentrations were related to 
PCBs or HCB plasma concentrations because 
these exposures were highly correlated. 
In the present study we also documented 
concentrations of HO-PCBs and PCP 
because several in vitro studies have revealed 
their potency in competitively inhibiting T4 
binding to TTR (van den Berg 1990). This 
T4-binding protein is implicated in the deliv-
ery of maternal T4 to the fetus across the pla-
centa (McKinnon et al. 2005) as well as the 
transport of T4 from blood into cerebrospinal 
fluid during brain maturation (Southwell et al. 
1993). However, experiments with TTR-null 
mice have shown that TTR is not essential 
for T4 distribution in brain (Palha 2002). 
Nevertheless, as would be predicted from toxi-
cologic data, a negative association was found 
between maternal PCP plasma concentrations 
and umbilical cord fT4 levels, but not with 
umbilical cord PCP, which has two times the 
binding affinity of the natural ligand T4 for 
TTR (van den Berg 1990). Moreover, it was 
the predominant CPC in the Inuit popula-
tion, and concentrations were mostly higher 
in umbilical cord plasma than in maternal 
plasma. Taken together, these findings seem 
to indicate that PCP may impede the transfer 
of maternal T4 to the fetus across the placen-
tal barrier to a certain extent by inhibiting 
maternal T4 binding to TTR. This mechanism 
may also have favored the transport of mater-
nal PCP to the fetal circulation, which may 
explain the higher concentration of this com-
pound in cord blood compared with maternal 
blood. The relation between maternal PCP 
and neonate fT4 concentrations was no longer 
evident at the later age, because there was no 
association between maternal or cord PCP and 
fT4 levels when the infants were 7 months of 
age (data not shown). The rapid maturation 
of the hypothalamus–pituitary–thyroid axis 
after the severing of the umbilical cord, which 
leads to the complete independence of the 
newborn from a maternal source of fT4, may 
explain such findings. However, these results 
should be interpreted with caution because no 
association was found with cord blood PCP 
concentrations even though they were highly 
correlated with maternal PCP levels (r = 0.85). 
Also, plasma Se concentrations of mothers and 
newborns included in the subsample analysis 
were lower than in the sample used for OCs (n 
= 80). Two other epidemiologic studies have 
looked at the association between CPC and 
TH concentrations in neonates. In another 
sample of Inuit newborns, Sandau et al. 
(2002) found a negative correlation between 
the sum of PCP and 14 HO-PCBs with cord 
fT4, whereas Otake et al. (2007) reported a 
positive correlation between 6 HO-PCBs and 
neonatal blood-spot fT4 obtained on a filter 
Table 5. Linear regression models of thyroid hormone and TBG plasma levels with organochlorines in 
plasma from 7-month-old Inuit infants.
Analyte  Thyroid parameter  No.  Univariate β  Standardized β
PCB-153 (µg/L)  TSH (mIU/L)  130  –0.09*  –0.23
  fT4 (pmol/L)  130  0.02  0.11
 T 3 (nmol/L)  130  –0.01  –0.12
  TBG (nmol/L)  132  0.02  –0.03
HCB (µg/L)  TSH (mIU/L)  128  –0.06  –0.13
  fT4 (pmol/L)  128  0.02  0.09
  T3 (nmol/L)  128  –0.01  –0.11
  TBG (nmol/L)  130  0.03  0.03
Standardized β adjusted for breast-feeding status at 7 months and serum lipid concentrations.
*p < 0.05. Environmental contaminants and thyroid hormone status
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paper. Other studies are needed to ascertain 
the potential effects of CPCs on neonatal TH 
concentrations, because the small sample size 
in the present study limits its conclusions.
The increase of T3 with concentrations of 
HO-PCBs in pregnant women may be attrib-
utable to selective or combined inhibition of 
sulfotransferase and type I deiodinase (D1) 
activities, as these metabolites have been shown 
to competitively inhibit D1 and diiodothy-
ronine sulfotransferases actions (Schuur et al. 
1998). Indeed, in adults, sulfotransferases irre-
versibly inactivate TH actions and facilitate 
D1 deiodination for complete degradation in 
the liver (Visser 1996). Interestingly, in fetuses 
sulfated T4 and T3 are elevated compared with 
adult concentrations and have been proposed 
to serve as a reservoir of inactive TH for subse-
quent activation by sulfotransferases at specific 
developmental stages (Darras et al. 1999). This 
difference in TH metabolism between fetuses 
and adults, especially for sulfotransferase and 
deiodinase activities, may explain the absence 
of HO-PCB effects on cord T3 compared with 
maternal T3. 
These findings suggest that the synthe-
sis or metabolism of transport proteins may 
be affected by environmental contaminants. 
Indeed, the negative association between 
PCB-153 and serum TBG concentration could 
by mediated by a diminution of TBG synthesis 
by the liver. Interestingly, we already reported 
a similar association in a population of neo-
nates from the Lower North Shore of the St. 
Lawrence River (Dallaire et al. 2008). Because 
commercial fT4 immunoassays overestimate 
the fT4 levels at high TBG concentration and 
underestimate it at low TBG concentrations 
(Demers and Spencer 2002), these results may 
indicate that contaminants affecting TBG 
concentrations introduce bias in the assess-
ment of the effects of thyroid toxicants on fT4 
levels. Most toxicologic studies have focused 
on the competitive binding assessment of 
environmental contaminants with T4, without 
evaluating their ability to modify transport 
protein synthesis. Consequently, the results 
cannot be corroborated on biological mecha-
nisms because toxicologic data are unavailable. 
Nevertheless, such an effect remains plausible. 
By analogy, Richardson et al. (2008) have 
recently shown that polybrominated diphenyl 
ether congener 47 has the capacity to decrease 
TTR mRNA expression in the liver by an 
unidentified mechanism. An assessment of 
transport protein biosynthesis modification 
by environmental contaminants is needed to 
clarify this question. 
Conclusion
In summary, in this study we did not find sim-
ilar effects of potential thyroid toxicants on TH 
homeostasis in mother and infant. Differential 
TH and contaminant metabolizing capacity 
between fetuses and adults may account for this 
discrepancy. There were also no associations 
between concentrations of PCB-153 and TH 
levels in Nunavik Inuit mothers and infants. 
However, a significant inverse relationship was 
found between maternal PCP levels and fT4 
umbilical cord concentrations. This finding 
is in agreement with the hypothesis regarding 
the capacity of CPCs to competitively inhibit 
T4 binding to TTR in humans. However, 
this result must be interpreted with caution 
because it was found in a subsample of the 
neonate population and consequently needs to 
be corroborated in larger studies. Nevertheless, 
epidemiologic studies of pregnant women suf-
fering from hypothyroxinemia (low fT4) have 
shown that reduced transfer of maternal fT4 
during fetal brain maturation can negatively 
affect the neurocognitive function in infants 
(Pop et al. 1999, 2003). Results from the neu-
rodevelopment assessment of the participating 
infants in this cohort will allow us to determine 
whether a reduction of fT4 concentrations 
during fetal development, perhaps mediated 
by PCP, may induce deficits similar to those 
observed in the offspring of hypothyroxinemic 
  pregnant women. 
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